Literature DB >> 10627126

Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants during chronic phase of chronic myeloid leukemia.

R A Clift, J Radich, F R Appelbaum, P Martin, M E Flowers, H J Deeg, R Storb, E D Thomas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10627126

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

Review 1.  Allogeneic hematopoietic cell transplantation: from experimental biology to clinical care.

Authors:  Razvan Diaconescu; Rainer Storb
Journal:  J Cancer Res Clin Oncol       Date:  2004-09-28       Impact factor: 4.553

2.  Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection.

Authors:  Keisuke Kato; Yasuko Kojima; Chie Kobayashi; Kazumasa Mitsui; Ryoko Nakajima-Yamaguchi; Kazuko Kudo; Toshihiro Yanai; Ai Yoshimi; Tomohei Nakao; Tomohiro Morio; Mureo Kasahara; Kazutoshi Koike; Masahiro Tsuchida
Journal:  Int J Hematol       Date:  2011-10-21       Impact factor: 2.490

3.  The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia.

Authors:  Vivian G Oehler; Ted Gooley; David S Snyder; Laura Johnston; Allen Lin; Carrie C Cummings; Su Chu; Ravi Bhatia; Stephen J Forman; Robert S Negrin; Frederick R Appelbaum; Jerald P Radich
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

4.  Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia.

Authors:  J P Uberti; M-A Agovi; S Tarima; M Haagenson; S Gandham; C Anasetti; K S Baker; B J Bolwell; M Bornhauser; K W Chan; E Copelan; S M Davies; J Finke; G A Hale; C Kollman; P L McCarthy; V Ratanatharathorn; O Ringdén; D J Weisdorf; J D Rizzo
Journal:  Bone Marrow Transplant       Date:  2010-04-19       Impact factor: 5.483

5.  Anti-CD45 radioimmunotherapy using (211)At with bone marrow transplantation prolongs survival in a disseminated murine leukemia model.

Authors:  Johnnie J Orozco; Tom Bäck; Aimee Kenoyer; Ethan R Balkin; Donald K Hamlin; D Scott Wilbur; Darrell R Fisher; Shani L Frayo; Mark D Hylarides; Damian J Green; Ajay K Gopal; Oliver W Press; John M Pagel
Journal:  Blood       Date:  2013-03-07       Impact factor: 22.113

Review 6.  Accelerated and blastic phase of chronic myeloid leukemia.

Authors:  J P Dutcher; P H Wiernik
Journal:  Curr Treat Options Oncol       Date:  2000-04

7.  Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia.

Authors:  Sonya Haslam
Journal:  Core Evid       Date:  2005-03-31

Review 8.  Biologic and clinical aspects of autologous stem cell transplantation with mobilized peripheral blood cells in chronic myelogenous leukemia.

Authors:  F Frassoni
Journal:  Curr Oncol Rep       Date:  2000-03       Impact factor: 5.945

Review 9.  Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review.

Authors:  Frédéric Baron; Rainer Storb
Journal:  Springer Semin Immunopathol       Date:  2004-07-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.